Evotec’s Post

Streamline your laboratory's UV-Vis workflows with confidence! 🧪✨ With OpenLab and the Cary 3500 UV-Vis, you're equipped with robust technical control, multi-level e-signature workflows, and comprehensive audit trail capabilities. Integration into your lab network has never been smoother. Say goodbye to the challenges of data integrity and embrace efficiency. https://bit.ly/44HequT #UVVis #pharma #DataIntegrity

Interested in learning more about fragment-based drug design and innovative tools? Join our free webinar! Discover how to use fragment drug design to create novel compounds and how BMaps can simplify your design process. 📅 Date: 10/17 🕚 Time: 11:00 AM - 12:00 PM ET 🔗 Register here: https://lnkd.in/ei_Ck9TJ Don’t miss this chance to enhance your lab’s efficiency and productivity with BMaps! 🚀 #DrugDiscovery #DrugDevelopment #FBLD #FBDD #ChemComp #MedChem #Webinar

Come see how you can use BMaps to do fragment based drug design, docking, rational design, and more!

How Effective Are Drug Tests Over Time? 🕒💊 How far back can drug tests detect use? Understanding detection windows is crucial. Which is why ARCpoint Labs of Manteca offers precise and dependable drug testing services, providing clarity for both employers and individuals. ARCpoint Labs of Manteca thus invites you to let us guide you through the intricacies of drug test detection. Contact us (209) 629-8282 or visit our expert team at 119 N Maple Ave STE A to learn more about ARCpoint Lab’s drug testing services. #DrugDetectionWindows #ReliableTesting #ARCpointLabs

😺 #ADCs and #TCEs : the cool cats of biotechs In the world of #pharma, Antibody-Drug Conjugates (ADCs) and T-Cell Engagers (TCEs) are like cats -they are precise, agile, and have a knack for finding exactly what they are targeting. 🎯 And just like with cats, you better know how to handle them or things can get a bit… unpredictable 😼 For us #QSP modelers, the challenge is real: 🐾 How do we model these complex little creatures? 🔍 How do we account for their unique #PK / #PD profiles? 🐱👤 And can we predict the on-target effects (without too much off-target “clawing”)? Whether it is figuring out ADC linker stability or capturing the nuances of TCE bispecific action, we need to model these next-gen therapies to optimize dosing and reduce toxicity 🔬📈 💡 Exciting news! This week Vantage Research will be presenting two posters at the #GMPSymposium2024, bringing some key insights to the table. These clues might just help us take ADC and TCE modeling to the next level Feel free to ping me to chat about it -no hairballs involved ✨

Hit Identification (Hit ID) - Identify and triage initial high-quality starting points. Part of our fully Integrated Drug Discovery (IDD) Platform. #HitID #HitIdentification #DrugDiscovery #IDD Click here to learn more: https://buff.ly/3TVRoge

When it comes to the regulation of Digital Therapeutics (DTx), Germany is pioneering new paths for its adoption. 🌍 Our newest blog post delves into the intricacies of Germany's approach to DTx regulation. Check it out here 👉https://hubs.li/Q02m-VkY0 #DigitalTherapeutics #DTx #RegulatoryAffairs

#Invitrox organizes performance studies to verify the #analytical #performance of your IVD. We identify the different specimen types (matrices) that can be used with the IVD and the storage and shipping conditions. Get in touch today to discuss your project! Invitrox.com

We are thrilled to announce our latest article in #Pharmaceutics: "Innovative Approaches to Optimize Clinical Transporter Drug-Drug Interaction Studies." Dive into groundbreaking research by Sabina Paglialunga, Natacha Benrimoh, and Aernout van Haarst from Celerion that tackles the complexities of transporter DDIs using innovative methodologies. Read now: https://lnkd.in/eZgEMSFT #DDI #DrugDevelopment #Pharmacokinetics #ClinicalResearch

I just wanted to share with you what Daresbury Proteins' TransHEK platform can do to support your needs for generation of small amounts of recombinant antibodies. Our approach can provide usable antibody amounts in 3 days post transfection as standard. Cell culture supernatants ready to use for affinity/specificity studies as part of hybridoma/affinity maturation/antibody candidate screens. Do you have antibody libraries waiting to be screened? Would you like to adopt the platform to speed up your discovery workflow? We can help with both. Please see the summary slide and contact details #diagnostics, #antibodies, #recombinant, #proteins, #pharmaceuticals, #pharma, #mAbs, #drugdiscovery, #drugscreening, #therapeutics LYVA Labs, Liverpool City Region Combined Authority, Growth Platform, STFC, Innovate UK